Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1996;27:1417-1419

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimode, K.
Right arrow Articles by Nagai, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimode, K.
Right arrow Articles by Nagai, A.

(Stroke. 1996;27:1417-1419.)
© 1996 American Heart Association, Inc.


Articles

Leukoencephalopathy-Related Cerebral Amyloid Angiopathy With Cystatin C Deposition

Koichi Shimode, MD, PhD; Shotai Kobayashi, MD, PhD; Kaoru Imaoka, MD; Nobuyuki Umegae, MD Atsushi Nagai, MD

the Third Internal Medicine Department, Shimane Medical University (Japan).

Correspondence to Koichi Shimode, MD, PhD, Third Internal Medicine Department, Shimane Medical University, 89-1, Enya, Izumo, Shimane 693, Japan.

Background We have described sporadic cases of cerebral amyloid angiopathy with cerebral hemorrhage showing a low cystatin C level in the cerebrospinal fluid detected by enzyme-linked immunosorbent assay. Recently, several cases of leukoencephalopathy in patients with cerebral amyloid angiopathy have been reported. We describe a sporadic case of leukoencephalopathy with cystatin C-type cerebral amyloid angiopathy diagnosed during life by enzyme-linked immunosorbent assay.

Case Description A 74-year-old man who had suffered from progressive dementia for 3 years was admitted with right hemiparesis, dysarthria, and ataxia. MRI revealed pontine infarction and multiple lacunar state with leukoaraiosis. We suspected cystatin C-type cerebral amyloid angiopathy because of the low level of cystatin C in the cerebrospinal fluid. The patient died of sepsis 3 months later, and the presence of leukoencephalopathy with cerebral amyloid angiopathy was confirmed by autopsy. Immunohistological examination disclosed cystatin C and ß-protein deposition in amyloid structures of the cortical cerebral arteries.

Conclusions Measurement of cystatin C in the cerebrospinal fluid by enzyme-linked immunosorbent assay is a useful method of diagnosing leukoencephalopathy related to sporadic cystatin C-type cerebral amyloid angiopathy.


Key Words: amyloid • cerebrospinal fluid • cystatins • leukoencephalopathy




This article has been cited by other articles:


Home page
StrokeHome page
S. Kobayashi, K. Okada, H. Koide, H. Bokura, and S. Yamaguchi
Subcortical Silent Brain Infarction as a Risk Factor for Clinical Stroke
Stroke, October 1, 1997; 28(10): 1932 - 1939.
[Abstract] [Full Text]